140 related articles for article (PubMed ID: 34895486)
1. Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia.
Konishi Y; Sklavenitis-Pistofidis R; Yue H; Ferrari F; Redd RA; Lightbody ED; Russo M; Perry J; Horowitz E; Justis AV; Shayegh NA; Savell A; Prescott J; Varmeh S; Nowak RP; Hamilton M; Auclair D; Marinac CR; Trippa L; Fischer ES; Ghobrial IM
Cancer Cell; 2022 Jan; 40(1):6-8. PubMed ID: 34895486
[No Abstract] [Full Text] [Related]
2. The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2.
Marchesi F; Pimpinelli F; Sperandio E; Papa E; Falcucci P; Pontone M; di Martino S; de Latouliere L; Orlandi G; Morrone A; Ciliberto G; Mengarelli A;
Br J Haematol; 2022 Jan; 196(2):362-367. PubMed ID: 34490627
[No Abstract] [Full Text] [Related]
3. COVID-19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis.
Garcia P; Anand S; Han J; Montez-Rath ME; Sun S; Shang T; Parsonnet J; Chertow GM; Schiller B; Abra G
J Am Soc Nephrol; 2022 Jan; 33(1):33-37. PubMed ID: 34645698
[No Abstract] [Full Text] [Related]
4. Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.
Gavriatopoulou M; Terpos E; Malandrakis P; Ntanasis-Stathopoulos I; Briasoulis A; Gumeni S; Fotiou D; Papanagnou ED; Migkou M; Theodorakakou F; Eleutherakis-Papaiakovou E; Kanellias N; Trougakos IP; Kastritis E; Dimopoulos MA
Br J Haematol; 2022 Jan; 196(2):356-359. PubMed ID: 34528249
[TBL] [Abstract][Full Text] [Related]
5. Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.
Terpos E; Trougakos IP; Gavriatopoulou M; Papassotiriou I; Sklirou AD; Ntanasis-Stathopoulos I; Papanagnou ED; Fotiou D; Kastritis E; Dimopoulos MA
Blood; 2021 Jul; 137(26):3674-3676. PubMed ID: 33861315
[No Abstract] [Full Text] [Related]
6. Covid-19 vaccination in patients with multiple myeloma: Focus on immune response.
Ludwig H; San-Miguel J; Munshi N; Sonneveld P; Mateos MV; Moreau P; Terpos E
Am J Hematol; 2021 Aug; 96(8):896-900. PubMed ID: 34057243
[No Abstract] [Full Text] [Related]
7. Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy.
Gastinne T; Le Bourgeois A; Coste-Burel M; Guillaume T; Peterlin P; Garnier A; Imbert BM; Drumel T; Mahe B; Dubruille V; Blin N; Lok A; Touzeau C; Tessoulin B; Jullien M; Vanthygem S; Béné MC; Moreau P; Le Gouill S; Chevallier P
Br J Haematol; 2022 Jan; 196(2):360-362. PubMed ID: 34476803
[No Abstract] [Full Text] [Related]
8. Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma.
Aleman A; Upadhyaya B; Tuballes K; Kappes K; Gleason CR; Beach K; Agte S; Srivastava K; ; Van Oekelen O; Barcessat V; Bhardwaj N; Kim-Schulze S; Gnjatic S; Brown B; Cordon-Cardo C; Krammer F; Merad M; Jagannath S; Wajnberg A; Simon V; Parekh S
Cancer Cell; 2021 Nov; 39(11):1442-1444. PubMed ID: 34706273
[No Abstract] [Full Text] [Related]
9. Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester.
Citu IM; Citu C; Gorun F; Sas I; Tomescu L; Neamtu R; Motoc A; Gorun OM; Burlea B; Bratosin F; Malita D
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215900
[TBL] [Abstract][Full Text] [Related]
10. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
Mulhern JG; Fadia A; Patel R; Ficociello LH; Willetts J; Dahne-Steuber IA; Pollan MC; Mullon C; DeLisi J; Johnson C; Mysayphonh C; Kossmann RJ; Anger MS; Hymes JL
Clin J Am Soc Nephrol; 2021 Nov; 16(11):1720-1722. PubMed ID: 34312162
[No Abstract] [Full Text] [Related]
11. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
[TBL] [Abstract][Full Text] [Related]
12. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
[TBL] [Abstract][Full Text] [Related]
13. Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients.
Maillard A; Redjoul R; Klemencie M; Labussière Wallet H; Le Bourgeois A; D'Aveni M; Huynh A; Berceanu A; Marchand T; Chantepie S; Botella Garcia C; Loschi M; Joris M; Castilla-Llorente C; Thiebaut-Bertrand A; François S; Leclerc M; Chevallier P; Nguyen S
Blood; 2022 Jan; 139(1):134-137. PubMed ID: 34818411
[No Abstract] [Full Text] [Related]
14. Homologous and Heterologous Covid-19 Booster Vaccinations.
Atmar RL; Lyke KE; Deming ME; Jackson LA; Branche AR; El Sahly HM; Rostad CA; Martin JM; Johnston C; Rupp RE; Mulligan MJ; Brady RC; Frenck RW; Bäcker M; Kottkamp AC; Babu TM; Rajakumar K; Edupuganti S; Dobrzynski D; Coler RN; Posavad CM; Archer JI; Crandon S; Nayak SU; Szydlo D; Zemanek JA; Dominguez Islas CP; Brown ER; Suthar MS; McElrath MJ; McDermott AB; O'Connell SE; Montefiori DC; Eaton A; Neuzil KM; Stephens DS; Roberts PC; Beigel JH;
N Engl J Med; 2022 Mar; 386(11):1046-1057. PubMed ID: 35081293
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.
Henriquez S; Zerbit J; Bruel T; Ouedrani A; Planas D; Deschamps P; Staropoli I; Hadjadj J; Varet B; Ermak N; Bouscary D; Willems L; Fouquet G; Decroocq J; Franchi P; Deau-Fischer B; Terrier B; Tamburini J; Chatenoud L; Schwartz O; Vignon M
Blood; 2022 Feb; 139(6):942-946. PubMed ID: 34905598
[No Abstract] [Full Text] [Related]
16. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
Hensley KS; Jongkees MJ; Geers D; GeurtsvanKessel CH; Mueller YM; Dalm VASH; Papageorgiou G; Steggink H; Gorska A; Bogers S; den Hollander JG; Bierman WFW; Gelinck LBS; Schippers EF; Ammerlaan HSM; van der Valk M; van Vonderen MGA; Delsing CE; Gisolf EH; Bruns AHW; Lauw FN; Berrevoets MAH; Sigaloff KCE; Soetekouw R; Branger J; de Mast Q; Lammers AJJ; Lowe SH; de Vries RD; Katsikis PD; Rijnders BJA; Brinkman K; Roukens AHE; Rokx C
PLoS Med; 2022 Oct; 19(10):e1003979. PubMed ID: 36301821
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer.
Zeng C; Evans JP; Chakravarthy K; Qu P; Reisinger S; Song NJ; Rubinstein MP; Shields PG; Li Z; Liu SL
Cancer Cell; 2022 Feb; 40(2):117-119. PubMed ID: 34986328
[No Abstract] [Full Text] [Related]
18. Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming.
Sablerolles RSG; Rietdijk WJR; Goorhuis A; Postma DF; Visser LG; Geers D; Schmitz KS; Garcia Garrido HM; Koopmans MPG; Dalm VASH; Kootstra NA; Huckriede ALW; Lafeber M; van Baarle D; GeurtsvanKessel CH; de Vries RD; van der Kuy PHM;
N Engl J Med; 2022 Mar; 386(10):951-963. PubMed ID: 35045226
[TBL] [Abstract][Full Text] [Related]
19. Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders.
Abu-Raya B; Madhi SA; Omer SB; Amirthalingam G; Giles ML; Flanagan KL; Zimmermann P; O'Ryan M; Safadi MA; Papaevangelou V; Maertens K; Wanlapakorn N; Diaz-Brito V; Tommelein E; Esposito S
Front Immunol; 2021; 12():808064. PubMed ID: 35003137
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination.
Izmirly PM; Kim MY; Samanovic M; Fernandez-Ruiz R; Ohana S; Deonaraine KK; Engel AJ; Masson M; Xie X; Cornelius AR; Herati RS; Haberman RH; Scher JU; Guttmann A; Blank RB; Plotz B; Haj-Ali M; Banbury B; Stream S; Hasan G; Ho G; Rackoff P; Blazer AD; Tseng CE; Belmont HM; Saxena A; Mulligan MJ; Clancy RM; Buyon JP
Arthritis Rheumatol; 2022 Feb; 74(2):284-294. PubMed ID: 34347939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
